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ABSTRACT
Various treatments have been proposed for vaginal agenesis. The authors describe successful
procedures using amniotic membranes as a graft on vaginoplasties. The amnion was not
stripped from the chorion. The results showed the vagina to be well formed and of normal
depth and caliber. (J GYNECOL SURG 8:25, 1992)
INTRODUCTION
Malformations of the vagina are an uncommon but serious problem. Their severity ranges fromcomplete vaginal agenesis, with or without functioning uterus, to vaginal shortening.
The treatment of certain gynecologic malignancies, such as vaginal adenocarcinoma or vaginal severe
dysplasia induced by DES, requires vaginectomy, which makes coitus impossible. In some instances, radical
hysterectomy for severe cervical dysplasia must be associated with vaginectomy because of the presence of
associated vaginal dysplasia. Vaginal construction or reconstruction has become a well-established method to
permit or restore sexual function, and a variety of procedures have been described. The most popular method
involves lining a surgically created space, either with a partial thickness skin graft' or with amnion.2-10
In 1934, Brindeau2 used human amnion to construct the vagina for a patient with mullerian agenesis.
Between 1939 and 1947, Burger3 used amnion more extensively for the same purpose. In 1973, Trelford et
al.7 successfully used fetal amnion to reconstruct the vagina during anterior exenteration.
In our study, amniotic membranes have been used to line the artificially constructed vagina. The authors
report their experience with the use of amniotic membranes.
PATIENTS AND METHODS
Between 1986 and 1990, amniotic membranes were used in 10 patients undergoing vaginoplasty for various
etiologies, shown in Table 1.
The age of the patients ranged between 14 and 59 years.
The same technical procedure of vaginoplasty was used for the 6 patients suffering from vaginal agenesis.
None of them had undergone a vaginoplasty anteriorly.
Amniotic membranes were placed into the neovagina created in cases of vaginal agenesis (n = 6) or into the
vesicorectal space remaining after vaginectomy (n = 4).
Under general anesthesia, the patient was placed in the lithotomy position, and the vaginal dissection was
performed. A vaginal pouch was created by blunt dissection, with the help of scissors. At the same time, a
laparoscopy was carried out to confirm the diagnosis and check the blunt dissection. When hemostasis had
been achieved, a vaginal mold (Fig. 1) was selected of a size just large enough to ensure firm application of the
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Table 1. Type of Vaginal Abnormality and Postoperative Functional Results
Vaginal length (cm)
Etiology of vaginoplasty Preoperative Postoperative Functional results
Vaginal agenesis (n = 6)(Rokitansky-Kuster-Hauser syndrome)
Vaginal malignancy (n = 4)
Vaginal adenocarcinoma (post-DES
exposure) (n = 1)





















"No sexual intercourse. Only the mold is used.
bFailure because of insufficient motivation.
cNormal vaginal capacity.
amniotic membranes, with which it was covered. The labia majora were approximated with silk sutures to
keep the mold in place. A Foley catheter was inserted before the blunt dissection and left for 48 hours. After
vaginectomy, simultaneously performed abdominally and perineally, the space between the bladder and the
rectum was used for application of the mold.
The membranes were taken immediately postpartum from a seronegative patient who had been afebrile and
whose membranes had been ruptured for less than 6 hours. In all cases, delivery occurred 3 to 6 hours before
vaginoplasty. Delivery was vaginal in all cases. Elective cesarean section was not a condition for use of the
membranes. The membranes are rinsed in sterile saline solution to remove all the blood and stored at 4°C in
a saline solution (without any antibiotic). In our surgical procedure, amniotic membranes were used, and the
amnion was not stripped from the chorion before its use.
The mold wrapped in amniotic membranes was inserted. Two silk sutures in the labia majora maintained the
mold in position. The entire procedure was completed in 20 minutes. All patients were given antibiotics for 6
to 7 days postoperatively.
FIG. 1. Rigid vaginal mold (diameter 3.5 cm, length 10 or 12 cm). The holes allow the drainage of vaginal exudations.
Two small holes (arrow) allow the mold to be fixed.
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FIG. 2. Nonrigid vaginal mold (diameter 3.5 cm, length 10 or 12 cm).
The mold was removed under light sedation 7 days later, and the newly constructed vagina was inspected
and cleaned. The amniotic membranes were found adherent to the vagina. A nonrigid mold (Fig. 2) was
inserted, and the patient was discharged the following day and advised to refrain from sexual activity for an
additional 2 weeks and to use the mold at night during this period. Dienestrol cream was used as a lubricant.
The patient then was encouraged to have sexual intercourse. All patients were reviewed 2 weeks and 1 month
postoperatively and then at monthly intervals.
RESULTS
All patients found the mold uncomfortable postoperatively, but all were mobile and required mild analgesia
only for the mold change on the seventh day. Routine urinary catheter insertion was performed in all patients
for 48 hours. All patients received prophylactic antibiotics, penicillin and metronidazole. No patient
developed a urinary tract infection. At the mold change, the amniotic membranes could be seen as a distinct
layer applied to the vaginal wall. At the end of the 7 days, the vaginal tunnel was covered with a smooth lining
with widespread but small areas of congestion.
By the fourth week postoperatively, healthy pink vaginal epithelium was visible with, in some cases, only
small areas of granulation tissue. Initial epithelialization was excellent. At the end of the 8 weeks, the vagina
was found to be well formed and was of normal depth and caliber. There were no adhesions, exúdate, drying,
or scarring. Constant use of the mold did not result in an inflammatory reaction with formation of a granuloma
in unmarried patients.
The rectum was not entered in any patient during vaginal dissection.
All patients were reviewed 2 weeks and 1 month postoperatively and then at monthly intervals. Vaginal
smears at 8 weeks postoperatively showed numerous squamous epithelial cells. In all cases of vaginal
agenesis, except one, epithelialization was complete, as proved by biopsy, which showed early epithelializa-
tion (at week 4-6) and mature vaginal epithelium by the end of 8 to 10weeks(Fig. 3). In one case, granulation
tissue was found, estrogen vaginal cream was not used by the patient. In cases of vaginectomy for gynecologic
malignancies, epithelialization took longer, about 2 to 3 months.
The anatomic and functional results are summarized in Table 1. The length of the vagina was found to vary
from 7 to 8 cm. All patients had greatly improved vaginal length and capacity as a result of this treatment.
Excellent results were achieved in all cases except one. The oldest patient discontinued the use of the mold
after leaving hospital. Two weeks postoperatively, there was complete vaginal closure. This failure could be
explained by insufficient motivation of the patient. In the other cases, the vaginal tissue remained supple, with
no evidence of fibrous tissue formation. Chronic granulation tissue was not observed, and vaginal shrinkage
did not occur.
The final result was related directly to the motivation of the patient and her use of the mold postoperatively.
To date, no long-term complications have been observed. Follow-up extends from 3 months up to 5 years.
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FIG. 3. Vaginal biopsy taken from the newly formed vaginal cavity 8 weeks after surgery. Mature vaginal epithelium.
Gomori's trichrome. x 120.
DISCUSSION
Various treatments have been described for vaginal agenesis. Frank1 ' reported graduated vaginal dilatation,
but this technique has given good results in less than 50% of patients. Williams'2 described the method of a
turned-in labial flap. Although the procedure did not require any graft, no satisfactory results were reported.
Indeed, the vaginal axis was often ill placed, and difficulties at the time of micturition and repeated urinary
tract infections were observed.
Creating a tunnel for congenital absence of the vagina is a step that is common to all surgical procedures.
The use or nonuse of a graft could be discussed, and if a graft is to be used, which tissue is best—skin,
intestine, or amnion.
The use of cecal or sigmoid bowel segments was reported by Baldwin13 in 1904. Though some authors
claimed good results, this method is a major surgical procedure with significant morbidity and mortality.
Turner-Warwick and Kirby14 have reported successful reconstruction of the vagina with the colocecum
without serious surgical complication, but profuse secretions, persistent unpleasant odor, and ulcération of the
mucosal surface could be the major side effects.
Wharton15 devised an operation based on the remarkable regenerative potential of granulation tissue in the
vaginal canal. To keep the space patent, a condom-covered mold was used. Mclndoe and Bannister1 modified
Wharton's operation by the additional step of transplanting a split-thickness skin graft into the newly formed
vaginal cavity held in place by a vaginal mold. The great variations in success rate, high incidence of
postoperative infection, necrosis of the skin graft, and scarring, however, made it less acceptable. Moreover,
the patient suffers considerable discomfort from the donor skin site, which may remain visible.
Myocutaneous flaps have been used by several authors. The gracilis myocutaneous flap has become very
popular in recent years, l6~19 but a serious disadvantage is the precarious vascularity of the flaps. In the series
of McCraw et al.20 of 22 patients, 6 suffered a totally catastrophic loss of the flap. The rectus abdominis flap
is another popular flap, but the singular complaint about it is the large abdominal donor-site defect,21 and the
operative time is long. The neurovascular pudendal thigh flap procedure is a feasible one that also can be used
reliably to reconstruct the vagina. The results from all the techniques with flaps described partial flap loss and
necrosis in an unacceptable failure rate. Moreover, such dissections caused a major skin scar and could be
indicated only for vaginal reconstruction after pelvectomy for pelvic cancer, when subsequent irradiation
must be carried out.
To overcome these difficulties, amnion alone with the clean mesenchymal surface placed toward the host
was used by several authors (Brindeau,2 Burger,3 Trelford et al.,6 and Dhall9). Dino et al.23 suggested
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sterilizing amniotic membranes. Trelford et al.5'7 found that membranes stored at 4°C in 0.5 N saline with
antibiotics were sterile at the end of 48 hours.
In our study, amniotic membranes were taken immediately postpartum (< 6 hours). Saline solution with
antibiotics was never used. Membranes were rinsed only in sterile physiologic solution (NaCl 0.9%).
Faulk et al.24 have demonstrated microscopic evidence of new vessel formation and suggested that an
angiogenic factor is produced by amnion. There is no problem with immune rejection because amnion does
not express histocompatibility antigens, and Akle et al.25 found no evidence of tissue rejection when amnion
was implanted subcutaneously in volunteers. Tancer et al.8 Dhall,9 and Ashworth et al.10 have reported
successful procedures using amnion as a graft on vaginoplasties. Removal of the more antigenic chorion has
been suggested to contribute to the successful use of the amnion. In the present study, however, the amnion
was not stripped from the chorion. Our results show the vagina to be well formed and of normal depth and
caliber. There was no problem of immune rejection. Sexual intercourse was reported to be satisfactory in all
cases. Vaginal smears and vaginal biopsy specimens were taken at follow-up visits. Vaginal epithelium was
present by 8 to 10 weeks.
In conclusion, amniotic membranes readily available, easily stored, and inexpensive can be used without
sterilization as a graft for vaginal reconstruction. The amniotic membranes adhere firmly, protect the
underlying granulation, and facilitate epithelialization. Hospitalization is considerably reduced, and major
skin defects occurring after myocutaneous flap reconstruction are avoided. No postoperative dilatation is
needed once normal sexual intercourse is resumed.
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